|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Eloxx Pharmaceuticals Inc. (ELOX)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-06-24 Purchase |
2019-06-26 4:51 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director |
200,000 | $9 | $1,800,000 | 4,900,249 (Indirect) |
View |
| 2019-06-24 Purchase |
2019-06-26 4:48 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director |
200,000 | $9 | $1,800,000 | 4,900,249 (Indirect) |
View |
| 2019-06-24 Purchase |
2019-06-26 4:44 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (China) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (Israel) IV L.P. Pontifax IV GP L.P. 10% Owner |
200,000 | $9 | $1,800,000 | 1,049,310 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-09-26 Exercise |
2019-09-27 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO, Chairman |
35,599 | $0 | 320,393 (Direct) |
View |
| 2019-09-26 Tax Withholding |
2019-09-27 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO, Chairman |
10,467 | $4.37 | 320,393 (Direct) |
View |
| 2019-09-26 Exercise |
2019-09-27 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO, Chairman |
35,599 | $0 | 320,393 (Direct) |
View |
| 2019-09-12 Option Award |
2019-09-13 4:10 pm |
N/A 2029-09-12 |
Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. CHIEF BUSINESS OFFICER |
150,000 | $6.47 | 150,000 (Direct) |
View |
| 2019-09-12 Option Award |
2019-09-13 4:10 pm |
N/A 2029-09-12 |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR |
100,000 | $6.47 | 100,000 (Direct) |
View |
| 2019-09-12 Option Award |
2019-09-13 4:10 pm |
N/A 2029-09-12 |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. COO |
225,000 | $6.47 | 225,000 (Direct) |
View |
| 2019-06-26 Exercise |
2019-06-27 5:39 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO |
35,599 | $0 | 355,992 (Direct) |
View |
| 2019-06-26 Tax Withholding |
2019-06-27 5:39 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO |
10,467 | $9.03 | 355,992 (Direct) |
View |
| 2019-06-26 Exercise |
2019-06-27 5:39 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO |
35,599 | $0 | 355,992 (Direct) |
View |
| 2019-05-29 Option Award |
2019-05-30 3:45 pm |
N/A 2029-05-29 |
Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director |
20,000 | $9.02 | 20,000 (Direct) |
View |
| 2019-05-29 Option Award |
2019-05-30 2:06 pm |
N/A 2029-05-29 |
Eloxx Pharmaceuticals Inc. | ELOX | Kleijwegt Martijn Director |
20,000 | $9.02 | 20,000 (Direct) |
View |
| 2019-05-29 Option Award |
2019-05-29 5:22 pm |
N/A 2029-05-29 |
Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia Director |
20,000 | $9.02 | 20,000 (Direct) |
View |
| 2019-05-29 Option Award |
2019-05-29 5:21 pm |
N/A 2029-05-29 |
Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director |
20,000 | $9.02 | 20,000 (Direct) |
View |
| 2019-05-29 Option Award |
2019-05-29 5:17 pm |
N/A 2029-05-29 |
Eloxx Pharmaceuticals Inc. | ELOX | Avnur Zafrira Director |
20,000 | $9.02 | 20,000 (Direct) |
View |
| 2019-05-29 Option Award |
2019-05-29 5:15 pm |
N/A 2029-05-29 |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax IV GP L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner |
20,000 | $9.02 | 20,000 (Indirect) |
View |
| 2019-05-29 Option Award |
2019-05-29 5:15 pm |
N/A 2029-05-29 |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax IV GP L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner |
20,000 | $9.02 | 20,000 (Indirect) |
View |
| 2019-05-29 Option Award |
2019-05-29 5:13 pm |
N/A 2029-05-29 |
Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director |
20,000 | $9.02 | 20,000 (Direct) |
View |
| 2019-05-29 Option Award |
2019-05-29 5:12 pm |
N/A 2029-05-29 |
Eloxx Pharmaceuticals Inc. | ELOX | Rubin Steven D Director |
20,000 | $9.02 | 20,000 (Direct) |
View |
| 2019-05-29 Option Award |
2019-05-29 5:10 pm |
N/A 2029-05-29 |
Eloxx Pharmaceuticals Inc. | ELOX | Seehra Jasbir Director |
20,000 | $9.02 | 20,000 (Direct) |
View |
| 2019-05-29 Option Award |
2019-05-29 5:08 pm |
N/A 2029-05-29 |
Eloxx Pharmaceuticals Inc. | ELOX | Veinrib Gadi Director |
20,000 | $9.02 | 20,000 (Direct) |
View |
| 2019-05-29 Option Award |
2019-05-29 5:07 pm |
N/A 2029-05-29 |
Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia Director |
20,000 | $9.02 | 20,000 (Direct) |
View |
| 2019-03-26 Exercise |
2019-03-28 4:15 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO |
35,599 | $0 | 391,591 (Direct) |
View |
| 2019-03-26 Tax Withholding |
2019-03-28 4:15 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO |
10,467 | $11.5 | 391,591 (Direct) |
View |
| 2019-03-26 Exercise |
2019-03-28 4:15 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO |
35,599 | $0 | 391,591 (Direct) |
View |
| 2019-01-30 Option Award |
2019-01-31 8:25 pm |
N/A 2029-01-30 |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. COO |
100,000 | $11.53 | 100,000 (Direct) |
View |
| 2019-01-30 Option Award |
2019-01-31 8:25 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. COO |
30,000 | $0 | 100,000 (Direct) |
View |
| 2019-01-30 Option Award |
2019-01-31 7:56 pm |
N/A 2029-01-30 |
Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. CHIEF BUSINESS OFFICER |
55,000 | $11.53 | 55,000 (Direct) |
View |
| 2019-01-30 Option Award |
2019-01-31 7:56 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. CHIEF BUSINESS OFFICER |
25,000 | $0 | 55,000 (Direct) |
View |
| 2019-01-30 Option Award |
2019-01-31 7:54 pm |
N/A 2029-01-30 |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR |
50,000 | $11.53 | 50,000 (Direct) |
View |
| 2019-01-30 Option Award |
2019-01-31 7:54 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR |
25,000 | $0 | 50,000 (Direct) |
View |
| 2019-01-30 Option Award |
2019-01-31 7:49 pm |
N/A 2029-01-30 |
Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO |
60,000 | $11.53 | 60,000 (Direct) |
View |
| 2019-01-30 Option Award |
2019-01-31 7:49 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO |
20,000 | $0 | 60,000 (Direct) |
View |
| 2019-01-30 Option Award |
2019-01-31 7:42 pm |
N/A 2029-01-30 |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO |
226,000 | $11.53 | 226,000 (Direct) |
View |
| 2018-12-26 Exercise |
2018-12-28 4:15 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO |
213,595 | $0 | 427,190 (Direct) |
View |
| 2018-12-26 Tax Withholding |
2018-12-28 4:15 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO |
83,038 | $12.6 | 427,190 (Direct) |
View |
| 2018-12-26 Gift |
2018-12-28 4:15 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO |
50,000 | $0 | 427,190 (Direct) |
View |
| 2018-12-26 Exercise |
2018-12-28 4:15 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO |
213,595 | $0 | 427,190 (Direct) |
View |
| 2018-06-06 Exercise |
2018-06-29 4:12 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia CEO |
349,400 | $0.0006 | 490,789 (Direct) |
View |
| 2018-06-06 Exercise |
2018-06-29 4:12 pm |
N/A 2024-04-26 |
Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia CEO |
349,400 | $0.0006 | 490,789 (Direct) |
View |
| 2018-06-25 Option Award |
2018-06-26 8:53 pm |
N/A 2028-06-25 |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. COO |
300,000 | $18.84 | 300,000 (Direct) |
View |
| 2018-06-25 Option Award |
2018-06-26 8:52 pm |
N/A 2028-06-25 |
Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. Chief Business Officer |
200,000 | $18.85 | 200,000 (Direct) |
View |
| 2018-06-18 Option Award |
2018-06-20 5:34 pm |
N/A 2028-06-18 |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. General Counsel and Secretary |
125,000 | $20.85 | 125,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 9:31 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Avnur Zafrira Director |
40,000 | $23.27 | 40,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:27 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Veinrib Gadi Director |
40,000 | $23.27 | 40,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:26 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Seehra Jasbir Director |
40,000 | $23.27 | 40,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:24 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Rubin Steven D Director |
40,000 | $23.27 | 40,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:22 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner |
40,000 | $23.27 | 40,000 (Indirect) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:22 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner |
40,000 | $23.27 | 40,000 (Indirect) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:19 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax IV GP L.P. 10% Owner |
40,000 | $23.27 | 40,000 (Indirect) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:19 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax IV GP L.P. 10% Owner |
40,000 | $23.27 | 40,000 (Indirect) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:17 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director |
40,000 | $23.27 | 40,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:15 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia CEO |
141,389 | $0 | 141,389 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:15 pm |
2018-06-15 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia CEO |
141,389 | $23.27 | 141,389 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:15 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia CEO |
40,000 | $23.27 | 141,389 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:12 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Kleijwegt Martijn Director |
40,000 | $23.27 | 40,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:08 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director |
40,000 | $23.27 | 40,000 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Mon, 21 Oct 2019 14:29:57 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |